. For example, Transwell systems enable the study of 3D chemotactic responses of the cells cultured on filters or in gels placed on the filters, but they lack the ability to image at high resolution in real time or to control many aspects of the local cellular microenvironments. Other 3D assays suspending cells in a gel or plating cells on beads within a gel provide a simple and effective means for monitoring cellular morphogenesis within an extracellular matrix (ECM) 7, 8 . However, sprouts or migration of cells from a solid bead differ from cellular morphogenesis in vivo. It is also difficult to produce a well-controlled microenvironment with similar dimensions to tissue structures in vivo.
Recognizing the need to better replicate the in vivo environment, we developed a novel hydrogel-incorporating microfluidic cell culture assay, which facilitates the interaction of cells in 3D ECM scaffolds, and thus better captures the complex behaviors that occur within the in vivo microenvironment compared with 2D in vitro assays 9 . Similar microfluidic platform protocols designed for neuroscience research 10 , gelatin-based cellular interaction 11 and bacterial chemotaxis 12 have enabled the integration of complex environmental factors and high-resolution in situ imaging. Our system is a multipurpose platform for local containment of ECM-mimicking hydrogels to supply precisely controlled conditions to the cells cultured on and/or inside. It also provides the flexibility necessary to study 3D cellular morphogenesis 13 , 3D homotypic/heterotypic cell-cell and cell-ECM interactions 9, 14, 15 , and 3D responses to biochemical gradients [16] [17] [18] , interstitial flow 15 , diffusion of soluble factors and various mechanical stimuli 19 with the same batch of cells at the same time. Furthermore, owing to the smaller length scales compared with traditional cultures, it requires lower volumes of reagents and media.
Applications of the method
The microfluidic platform described in this protocol has been widely applied to 3D cell culture in various applications, including 3D angiogenic responses under the gradient of growth factors introduced in media 13, [16] [17] [18] or secreted by cocultured tumor cells 14 . The angiogenic structure of networks of endothelial cells in the hydrogel was confirmed as 3D and regulated by surface treatment of the microfluidic channel 13 . We also found that primary hepatocytes cultured on the hydrogel under interstitial flow formed 3D tissues, enabling detoxification and regulating capillary morphogenesis of cocultured endothelial cells 15 . We investigated the endothelium-dependent migration of smooth muscle cells cocultured with ECs 20 , 3D axonal responses under various growth factor gradients 21 and 3D cancer metastatic processes 14, 22 . Cancer cells invaded and migrated in 3D into the hydrogel and finally intravasated through the endothelial monolayer cultured in a microfluidic channel 14 . We modified the microfluidic design to create a more stable concentration gradient that was better able to represent the metabolic activity of cells 18, 23 and also successfully manufactured a platform of similar design suitable for high volume manufacture using hot-embossed plastics 24 . The structure, results and possible
Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels applications of the platform technology have been described in two recent reviews 9, 25 . In this protocol, we describe the basic procedure for using a hydrogel-incorporating microfluidic assay using angiogenesis studies as an example. On the basis of the protocol, the readers can easily integrate conventional soft lithography technology 26 to explore a wide variety of applications with small modifications in cell seeding and culturing procedures.
Experimental design
Microfluidic systems are fabricated in polydimethylsiloxane (PDMS) using standard soft lithographic methods. Other materials such as standard tissue culture plastics can also be used in combination with either hot-embossing or injection molding methods. It is preferable if all features are of uniform depth to enable simple single-stage fabrication. Drilling or coring holes through the full thickness of the device provides direct access to the gel-containing and medium channels, and bonding a coverslip to the side with imprinted features produces closed channels. The entire process of microfluidic cell culture, including fabrication, cell culture and analysis, is explained here. From various microfluidic device designs, we chose to focus on the one most widely used for 3D cell culture assay, which is composed of four gel regions and three channels, each of which is individually accessible (Fig. 1) . The cells are usually cultured in the center channel, and the other two side channels act as control channel and condition channel, respectively. The interior of the channels is coated with ECM proteins to promote cell adhesion. In particular, the described method of coating with poly-d-lysine (PDL) hydrobromide has been confirmed to promote 3D capillary morphogenesis into the hydrogel 13 . Finally, we illustrate the method for introducing a hydrogel solution (type I collagen gel as the prototypical example), controlling gel stiffness, seeding cells inside the gel region and immunostaining the cells after the experiment using a method that is specially optimized for the microscale. In addition to general instructions, we give specific details for how to evaluate the angiogenic response to a gradient in vascular endothelial growth factor (VEGF).
The part of the protocol describing the manufacture of the microfluidic device can be divided into the master fabrication (photolithography; Steps 1-8) and mold fabrication (soft lithography stages; Steps 9-15). The first stage only needs to be performed once per master type, as a master can be used multiple times in the subsequent stages. For the general biology community, the photolithography stage may require equipment not available in the typically stocked laboratory plus assistance from someone experienced in microfluidics or microfabrication. Further details can also be acquired from other protocols (see refs. 12,26) . However, the soft lithography stage only requires equipment (vacuum desiccator and dry oven) that is commonly available in a biology laboratory and is easier to follow without specialist knowledge. Further details about how to perform soft lithography can be found in other protocols (see refs. 12,26) .
Limitations
Whereas the small dimensions within the device are essential for realistic cell-cell signaling to occur, they also impose certain inherent limitations. Typical biochemical assays could be difficult to perform because of the small cell number (typically <1,000 cells), so methods of interrogating biological function are generally restricted to antibody staining for the distribution, concentration or activation of various intra-or extracellular biomolecules. Channel structure has been modified in similar devices to increase cell number to enable conventional biochemical analysis of ELISA or RT-PCR. Loading the system with hydrogel, medium and cells requires training but can usually be mastered in a day. Imaging is typically performed by conventional microscopy including confocal microscopy, but other methods such as transmission electron microscopy are also possible. (1 mg ml − 1 ) using a stirrer at room temperature (23 °C) . Sterilize the solution with a 250-ml bottle-top 0.2-µm filter. Dispense the sterile solution into aliquots of 1 ml each and store at -20 °C for up to 1 year for future use. Triton X-100 solution Dilute 0.1% (vol/vol) Triton X-100 in distilled deionized water and store it at room temperature. It can be stored for up to 1 year if tightly sealed. Phosphate-buffered saline (PBS, 10×) with phenol red Dissolve 63.6 mg of phenol red sodium salt in 400 ml of 10× PBS using a vortex generator. Sterilize the solution using a 250-ml bottle-top 0.2-µm filter and store it at room temperature. It can be stored for up to 1 year if tightly sealed. NaOH solution, 0.5 N Dissolve 5 g of NaOH tablets in 230 ml of distilled deionized water by stirring. Add sterile deionized water up to 250 ml into the solution. Sterilize the solution using a 250-ml bottle-top filter (0.2 µm) and store it at room temperature. It can be stored for up to 1 year if tightly sealed.  crItIcal Add no more than 1 g of NaOH tablets into sterile deionized water each time. If NaOH tablets are added into sterile deionized water at once, the solution will become hot.
MaterIals

REAGENTS
• • • • • • • • • • • • • • • • • • • • Plasma• • • • • • • • • proceDure
Fabrication of the master (photolithography)
• tIMInG 3 h 1| Dispense about 4 ml of SU-8 100 onto a cleaned and dehydrated 4-inch silicon wafer.
2|
Coat the dispensed SU-8 uniformly on the wafer using a spinner by ramping up to 500 r.p.m. at 100 r.p.m. s − 1 for 10 s (for 150-µm-thick patterns).
3|
Ramp to 2,000 r.p.m. at an acceleration of 300 r.p.m. s − 1 for 30 s (for 150-µm-thick patterns).
4|
Prebake the wafer for 20 min at 65 °C and for 50 min at 95 °C on a hot plate (for 150-µm-thick patterns).  crItIcal step Keep the coated wafers level (Fig. 2a ).
5| Use a transparency photomask printed at 20,000 dpi to produce the master by exposing the wafer to an appropriate dose of UV light as per Microchem's protocol (Fig. 2b) .
6|
After exposure, bake the wafer for 1 min at 65 °C and for 12 min at 95 °C on the hot plate (for 150-µm-thick patterns).
7|
Develop for 15 min in photoresist developer (for >150-µm-thick patterns; Fig. 2c ).
8|
Rinse the substrate briefly with IPA and gently dry it with pressurized nitrogen gas.  pause poInt The master can be stored indefinitely (under a cover to prevent dust exposure) until further use.
Fabrication of pDMs molds (soft lithography)
• tIMInG 7 h 9| Tape (using Scotch tape) the master securely on a Petri dish (100 mm in diameter) in order to prevent the PDMS solution from percolating down through the wafer.
10|
Blow dust particles off the wafer using pressurized nitrogen gas.
11| Take a disposable plastic cup and fill it with Sylgard 184 silicone elastomer base and the curing agent in a 10:1 weight ratio, and then mix the solution using a metal spatula.
12|
Pour the mixed solution into the Petri dish containing the master to the desired thickness (4-5 mm) and degas to remove air bubbles trapped in patterns.
13|
Cure the solution in an oven at 80 °C for 1 h 30 min (Fig. 2d ).
14|
Use a scalpel to cut out the cured PDMS and remove PDMS from the wafer (Fig. 2e ).
15|
Punch holes through the reservoir pattern at appropriate points using a dermal biopsy punch (disposable biopsy punches, 4 mm). To make inlets for hydrogel filling, punch holes using another punch (disposable biopsy punches, 1 mm; Fig. 2f ).
16|
Apply and detach pieces of Scotch tape on the PDMS to remove small particles, which can cause contamination and leakage of the bonded device.
17|
Place the devices in a glass beaker with deionized water and cover the flask with aluminum foil. Use an autoclave to sterilize them at 120 °C for 20 min (a wet autoclave). For effective sterilization, make sure that the devices are not stuck to each other.
18|
Place the devices in a clean box using a pair of sterilized tweezers (do this step in a sterile laminar flow hood), with the channel side facing up, and then sterilize again using an autoclave at 120 °C for 20 min (a dry autoclave).  crItIcal step Both wet and dry autoclaves are recommended for complete sterilization.
19| Dry the box containing sterile devices in an oven at 80 °C for at least 4 h.  pause poInt These devices can be stored at room temperature for up to 1 month before bonding to glass coverslips.
cleaning glass coverslips • tIMInG 5 h 20| By using pressurized nitrogen gas, blow off particles adhering to the glass coverslips.
21|
Autoclave the glass coverslips in a clean pipette tip box at 120 °C for 20 min and dry them in an oven at 80 °C for more than 4 h.  crItIcal In all steps after sterilization, the autoclaved coverslips and devices should be handled in sterile environment (in laminar flow hood with sterilized gloves).
Device assembly • tIMInG 10 min 22| Place the devices and glass coverslips in a plasma cleaner, the channel side facing up (Fig. 3) .
23|
Turn on a vacuum pump and wait until pressure drops below 600 mTorr. It takes about 30 s. In this bonding step, the working conditions may vary depending on the specifications of the plasma cleaner and vacuum pump. Working conditions (vacuum time and working pressure) should be optimized.
24|
Turn on the plasma cleaner to treat the surfaces of PDMS and glass coverslips for 50 s. A pale violet color should be observed in the vacuum chamber during this process. 26| Bond the device to the glass coverslip and press the device softly with a sterile pair of tweezers, avoiding pressure on the channel area (Fig. 3b) .
? trouBlesHootInG pDl coating of the microchannels • tIMInG 5 h 27| Fill the channels with 60 µl of surface coating solution (Fig. 3c) . As a surface coating solution, various polymers (PDL, poly-l-lysine (PLL), and so on) and ECMs (fibronectin, collagen, Matrigel and so on) can be used according to desired cell types. table 1 summarizes available surface coating solutions for various cell types. In an example application of angiogenesis with type I collagen as hydrogel, a PDL (1 mg ml − 1 )-coated channel surface is preferred for endothelial cell culture, which can prevent the detachment of collagen gel, resulting in 3D capillary morphogenesis into the type 1 collagen 13 .
28| Put the devices in an incubator for >4 h.
29|
Remove the PDL solution in the channels thoroughly using an aspirator.
30|
Fill the channels with 150 µl of sterile deionized water, and then wash them more than three times with a micropipette. Repeat this washing process twice. Excess PDL molecules can cause cell damage.  crItIcal step This is different from a conventional surface coating protocol. Do not wash with PBS solution, as this makes white stains in the microfluidic channel and interrupts hydrogel filling in the desired position. 31| Aspirate all microfluidic channels completely (Fig. 3d) .
surface hydrophobicity restoration • tIMInG 1 d 32| Place the coated devices in a sterile dish and place it at 80 °C in an oven for at least 24 h, but no longer than 72 h. It takes over 24 h to restore hydrophobicity of the bonded surfaces.  crItIcal step Surface modification for the PDMS bonding (see Steps 22-26) may lead to unintended breakage of optimal surface tension during the gel-filling step. Therefore, hydrophobicity of the surfaces should be obtained.
collagen gel solution preparation • tIMInG 5 min 33| To make 200 µl of 2.0 mg ml − 1 , prepare 10× PBS with phenol red, 0.5 N NaOH solution, collagen type I and deionized water. Keep all solutions on ice. (Note that cells can also be added to the collagen gel solution for the experiments requiring 3D cell seeding or coculture with another cell type.) 34| Calculate the exact amount of collagen type I solution needed on the basis of the collagen solution stock density. A quantity of 400 µg of collagen is needed to make 200 µl of 2.0 mg ml − 1 density collagen type I gel. The protocol described below is, as an example, for pH 7.4 collagen solution using one common stock density of 3.67 mg ml − 1 , but any density in the range of 3-4 mg ml − 1 may be used.
35|
Add a fixed amount (20 µl) of 10× PBS with phenol red solution into a 1-ml tube.
36| Add 7.9 µl of 0.5 N NaOH solution into the same tube. The amount of NaOH solution can be adjusted according to the desired pH.  crItIcal step Be careful not to leave any residue in the pipette tip, as slight differences in amount of 0.5 N NaOH solution may alter the pH. (ii) Place the cell suspension in ice to cool down for 5 min.  crItIcal step This step is required for avoiding pre-polymerization of the collagen gel suspension. (iii) Add 20 µl of prechilled cell suspension to the solution and stir it gently using a large pipette tip.
 crItIcal step Use a large pipette tip to reduce shear stress, which will have an effect on cell function and/or viability. (iv) Add 43.1 µl of deionized water to the cell-embedded solution to create the total required volume (200 µl) and carefully mix.  crItIcal step Use a large pipette tip to prevent cell damage.
39|
Check that the pH of the medium is correct using a pH meter. If you follow the above process, the pH of the resultant collagen gel should be about 7.4. The color of the collagen solution can be a good indicator for the initial pH (Fig. 4) . In addition to using collagen type 1 as scaffold, various hydrogels (Matrigel, hyaluronic acid, hydrogel mixture and so on) can be used.
collagen gel filling • tIMInG 40 min 40| Prepare a humid chamber and put it in a CO 2 incubator to keep warm before gel filling.
41|
Gently and slowly fill the collagen gel solution into all four hydrogel scaffold regions with a 10-µl micropipette. Collagen gel solution is easily fixed in hydrogel scaffold regions because of the surface tension caused by posts in the hydrogel region (Figs. 3e and 4c,d) .
? trouBlesHootInG
42|
Place the gel-filled device in the prepared humid chamber with the channel side facing up.
43|
Put the humid chamber in a CO 2 incubator for 30 min to allow the collagen to gel (Fig. 4b) .
44|
After incubation, place the device in a Petri dish and fill it with medium in all channels.
45|
Place the device in a CO 2 incubator.  pause poInt If cells are not already seeded, the device can be stored in a CO 2 incubator for 2-3 d before cell seeding. 
48|
Add an appropriate amount of medium to obtain the proper density of cells for seeding. For hMVECs, 2 million cells per ml is generally suitable.
cell loading and culture in the microfluidic platform • tIMInG 1 h 49| Aspirate the medium from all reservoirs of the device and add 50-60 µl of the cell suspension in one reservoir of the cell channel ( Fig. 5a ; the upper middle reservoir). The pressure difference between the cell channel (middle) and the condition/ control channels (right/left channels) enables interstitial flow, and the cells are consequently more likely to connect and adhere to the side of the scaffold (Fig. 5b) . Cells can be seeded into one or both side channels as well as in the center channel. As the channels are independent and separately accessible, different cell types can be introduced for various applications (hMVECs with cancer cells, cancer spheroids, smooth muscle cells (SMCs), neutrophils, and so on). For most cell types, 50-60 µl of cell suspension should be applied to the reservoirs (Fig. 5c) . The optimal concentration of cell suspension lies between 0.5 million cells per ml and 5 million cells per ml.
50|
Put the device in a CO 2 , incubator for 30 min to allow the cells to attach to the surface of the cell channel and form a monolayer on the side of scaffold. Incubation time can be adjusted depending on cell types, from 30 min to several hours.
51|
After incubation, aspirate the medium from the cell channel carefully.  crItIcal step Aspirate the medium carefully by placing the aspiration tip at the outside edge of the reservoir to prevent cell detachment.
52|
Add 50-60 µl of medium and place droplets in all six reservoirs (100-120 µl per channel). the volume of medium added, and from device handling, but the induced perturbations generally stabilize in about 30 min.
53|
Place the device in a CO 2 , incubator ( Fig. 5d) for 1 d. If you are using hMVECs, seeded hMVECs should form a confluent endothelial monolayer in 1 d (Fig. 5b,e) . ? trouBlesHootInG chemoattractant treatment and medium exchange • tIMInG 10 min 54| Remove the medium from all six reservoirs and add 100-120 µl of fresh medium to the cell channel and control channel.  crItIcal step To avoid cell death due to evaporation of medium, the total amount of fresh medium applied to two reservoirs connected by one channel should be more than 100 µl. The amount of medium in all reservoirs should be the same (by pipette) to avoid initial fluctuation.
55|
Add the same volume of medium with chemoattractants, chemorepellents or growth factors in the condition channel. In the case of human VEGF, fill with EGM-2MV medium supplemented with 50 ng ml − 1 recombinant VEGF to generate a gradient across the gel scaffold. Culture the cells for a further 24 h.
56|
Replace the medium daily by aspirating out the medium in the channels and adding 100-120 µl of fresh medium. The gradient reaches a steady state after about 30 min for a protein of 40-kDa molecular weight (e.g., VEGF), but it will dissipate over time if not replenished by either another medium change or by introducing a steady, slow flow through the channels by peristaltic or syringe pump. Without slow perfusion, linearity can be maintained for 24 h and easily restored by daily replacement of medium, which enables multiple experiments with the same batch of cells (Fig. 6) .  crItIcal step The time to establish a gradient is determined by the diffusion coefficient of the applied protein in the hydrogel, and it can also be affected by matrix binding. Slope can be visualized by a fluorescent molecule (e.g., dextran) and also simulated by conventional computational fluid dynamics (CFD) software (Fig. 6a,b) . After applying a chemical gradient, cellular responses can be monitored and quantified daily by conventional microscopy (Fig. 6c,d) . Medium or cells in the channel can be collected for biochemical or PCR analysis.
cell staining • tIMInG variable 57| At the desired cell culture endpoint, remove the remaining cell culture medium in all reservoirs by vacuum aspiration.  crItIcal step when aspirating medium or other solutions from the reservoirs, aspirate the medium carefully by placing the aspiration tip at the outside edge of reservoirs to prevent cells from detaching.
58|
Rinse the channels of the device with PBS. Fill 90-100 µl of PBS in one side of the reservoirs, then let it flow along the channels and check to ensure that it also filled the opposite reservoirs. Remove PBS in all reservoirs of the device. Repeat this step twice.
59|
Add 50-60 µl of 4% (wt/vol) PFA in all reservoirs and leave it to stand for 15 min for cell fixation. ! cautIon Wear suitable protective clothing and gloves when working with 4% (wt/vol) PFA. (e) In 4 d of culture, hMVECs form an intact monolayer in the channel and on type 1 collagen walls. Actin filaments and nuclei were then stained with rhodamine phalloidin (yellow) and 4′,6-diamidino-2-phenylindole (DAPI, blue), respectively. Scale bar, 50 µm. EC monolayer was imaged by confocal microscope 13 and its diffusion coefficient was measured by fluorescent dextran diffusion 13, 14, 18 .
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61|
Wash the channels twice with PBS as described in Step 58. ! cautIon The first wash of PBS should be disposed into the PFA waste bottle.
62|
Add 50-60 µl of 0.1% (vol/vol) Triton X-100 in each reservoir for solubilization and permeabilization of cell membranes. Let it incubate on the benchtop for 5min.
63|
Aspirate 0.1% (vol/vol) Triton X-100 and wash twice with PBS as in Step 58.  pause poInt The device filled with PBS can be stored for 1-2 d at 4 °C in a refrigerator before fluorescent staining.
64|
If you are performing fluorescent staining, follow option A. If you are using antibodies, follow option B. These methods can be combined. (ii) Remove PBS using a device with vacuum aspiration. ? trouBlesHootInG Troubleshooting advice can be found in table 2. 
antIcIpateD results
The described platform allows for a large number of different experimental cell culture designs, depending on which channels or gel regions contain cells, the types of cells used and the nature of biochemical gradients or flow that are imposed. We first focus on the results obtained for the specific case described above, that of endothelial cells being seeded in the center channel with no cells seeded elsewhere in the system (either the side channels or the gel regions), and in the case of a gradient of growth factor applied on one side to induce angiogenesis. Figure 7 shows successful culturing of hMVECs in the cell channel and a 3D sprouting angiogenic response in the direction of increased VEGF concentration (from the right side). Cells can be observed to progressively invade 3D into the type 1 collagen hydrogel toward the right side where a higher VEGF concentration has been introduced. Sprouting of the endothelial monolayer is observed only on the right side of the center channel, leaving the left side (no added VEGF) stable 14 . By using confocal microscopy, the monolayer has been demonstrated to be confluent over the face of the gel and the 3D nature of the capillaries has been confirmed. Other cell types show a variety of responses when seeded in the center channel and put in contact with a collagen hydrogel (Fig. 8) . The gradient of growth factors or chemoattractants can regulate both the morphology and the degree of cellular morphogenesis into the collagen hydrogel. Various experimental modes of cell seeding and morphogenesis in hydrogel incorporating microfluidic assay are listed in Figure 9 .
When hMVECs are seeded in the center channel and another cell type (e.g., cancer cells, 10T 1/2) is seeded and cultured in the side channel, paracrine interactions occur across the ~1 mm hydrogel region (Fig. 10) . Various responses can be observed. In some cases, cancer cells induce a sprouting response in the endothelial monolayer, similar to that found with added VEGF 8 . In other cases, the added cells migrate through the gel and interact with the other cells or monolayer, inducing cellular morphogenesis in some instances and suppressing it in others 14, 15, 20 . The microfluidic cell culture assay also allows the study of 3D cell-cell interactions and cell-ECM interactions 25 , especially for the evaluation of new synthesized biodegradable polymers (hyaluronic acid, synthetic peptides and so on) or other ECM materials (Matrigel, fibrin and so on) 27 . Cocultures of cancer cells-endothelial cells (Fig. 10b,d ) 8 , hepatocyte-endothelial cells 10 and smooth muscle cells (SMCs)-endothelial cells (Fig. 10c) 11 have already been realized in order to enable the study of cellular morphogenesis and interactions. We have proved that the assay can generate well-defined biochemical and biophysical stimuli to multiple cell types interacting with each other, thereby replicating many aspects of the in vivo microenvironment; this has considerable implications for drug discovery and artificial organ systems in vitro and offers time and cost benefits for drug screening. (10T 1/2 ; right channel) and ECs (hMVECs; center channel). Active 3D sprouting angiogenesis into type 1 collagen is monitored (into left hydrogels), while the hMVEC monolayer is stabilized by the presence of SMCs (right hydrogels). 10T 1/2 migration was also activated by the existence of the hMVEC monolayer in the center channel. Actin filaments and nuclei were stained with rhodamine phalloidin (yellow) and DAPI (blue), respectively. (b) GFP-transfected glioblastoma cells (U87MG) (white arrowheads) transmigrated through the hMVEC monolayer. Colors indicate actin (white), nucleus (blue) and GFP (green). Scale bars, 50 µm. (c) Interaction between SMCs (white arrowhead) and hMVECs (blue arrowheads). An SMC touches the hMVEC monolayer with its filopodia, and becomes adhered to the monolayer. Colors indicate actin (white), nucleus (blue) and EC-specific primary antibody (green). Scale bars, 50 µm. (d) GFP-transfected breast cancer cell MDA-MB-231 (white arrowhead) interacting with hMVEC (blue arrowheads) sprouts in a type 1 collagen scaffold. Colors indicate actin (white), nucleus (blue) and GFP (green). Scale bars, 100 µm. (e) Primary neurons generating axons toward GFP-transfected U87MG (white arrowheads). Colors indicate actin (white), nucleus (blue) and GFP (green). Scale bars, 100 µm.
